Insperity (NSP) Stock Could Be 16% Undervalued After SHRM26 HRScale Spotlight

Insperity, Inc.

Insperity, Inc.

NSP

0.00

Insperity (NSP) put its HR360, HRCore and HRScale platforms in the spotlight at SHRM26, using the high profile HR conference to showcase how its technology and service mix supports workforce management and HR administration.

Insperity’s SHRM26 presence comes after a mixed stretch for investors, with the share price up 28.52% over 90 days but the 1 year total shareholder return down 38.81%. This points to improving short term momentum following a weaker longer period.

If Insperity’s HR focus has you rethinking where growth might come from next, it could be worth scanning the market for automation plays and checking out 31 robotics and automation stocks

With Insperity stock recovering over the past 3 months but still showing weaker multi year returns and an intrinsic value estimate below the current share price, investors face a key question: is there genuine upside left, or is future growth already priced in?

Most Popular Narrative: 16% Undervalued

With Insperity last closing at $34.11 against a widely followed fair value estimate of $40.50, the current narrative focuses on an earnings recovery story built on its HR platforms and Workday partnership.

The upcoming launch of Insperity HRScale, a joint solution with Workday, targets a broader and more lucrative mid-market segment, leveraging both advanced HR technology and comprehensive services; this is expected to drive higher revenue growth and improved operating leverage as premium pricing and larger average client size become possible.

Curious what kind of revenue growth, margin rebuild and future earnings multiple have to come together to support that fair value story? The underlying assumptions connect HRScale traction, pricing power and expanding client size into one tightly argued earnings path. The full narrative lays out how those moving pieces need to line up to justify the current valuation gap.

Result: Fair Value of $40.50 (UNDERVALUED)

However, the Insperity narrative still hinges on healthcare and benefits costs not running ahead of pricing changes and on the Workday partnership delivering returns that justify its multi year investment burden.

Next Steps

If this Insperity narrative feels finely balanced between opportunity and concern, consider acting while the details are fresh and weigh the 3 key rewards and 1 important warning sign carefully.

Looking for more investment ideas beyond Insperity?

Before moving on from Insperity, give yourself a broader view of the market by checking a few targeted stock lists that line up with different investing angles.

Use the Simply Wall St Screener to uncover stocks that match your style so you do not miss opportunities sitting outside your current watchlist.

  • Target potential mispricings by scanning 44 high quality undervalued stocks that combine solid fundamentals with more attractive pricing.
  • Strengthen your income stream by reviewing 7 dividend fortresses built around higher yield payouts.
  • Dial down portfolio risk by focusing on companies from the 66 resilient stocks with low risk scores that score well on resilience.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.